Clinical evaluation of the efficacy of Sushrutas Koshatakyadi yavagu in madya visha (Alcoholic liver disease)W.S.R.T. Fatty liver - NI

Dr Athulya CM0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年4月29日

试验速览

暂无简介。

•1. Patients of both sex with history of regular alcoholic intake for more than 5
•2.Patients having fatty changes in the liver.
•3. Patients having elevated Gamma glutamyl transferse enzyme.
•4.Patients having alterations in the LFT
•5.Patients of age group 18 to 60 years
•6.Participants irrespective of gender, caste, religion and economic status.
•7. Patients who are ready to sign the consent form.

•1.Patients having progressive stage of alcoholic liver disease like severe hepatitis ,
•ascitis ,cirrhosis cancer etc.
•2.Patients with fatty liver change due to other cause rather than alcohol.
•3.Patients having any other infections like hepatitis B or C,obstructive Jaundice
•(Diagnosed clinically and biochemically)
•4.Patients who are pregnant and lactating mothers.
•5. Patients who are having other systemic disease like cancer Hypercholestremia,
•cardiac or renal diseases.
•6.Patient with history of Gastritis, peptic ulcers, bleeding ulcer.

发起方

Dr Athulya CM